# Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)

> **NCT03043508** · — · UNKNOWN · sponsor: **M.D. Anderson Cancer Center** · enrollment: 45 (actual)

## Conditions studied

- Genetic Mutation
- MEN1

## Interventions

- **OTHER:** Chart Review
- **BEHAVIORAL:** Questionnaire

## Key facts

- **NCT ID:** NCT03043508
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04-10
- **Primary completion:** 2025-04-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2019-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03043508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03043508, "Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03043508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*